<DOC>
	<DOCNO>NCT01361373</DOCNO>
	<brief_summary>Background : Cerebral palsy ( CP ) main cause childhood immobility define non progressive injury develop central nervous system child young 3 year , result neurological musculoskeletal abnormality . The main pathophysiological cause encephalopathy prematurity ( periventricular leukomalacia ) hypoxic ischemic encephalopathy . Infections , infracts migration defect less common cause CP . The brain injury lead functional motor impairment impact daily activity commonly manifest movement disorder : pyramidal , lead spasticity extra-pyramidal lead dystonia chorea . In case extensive brain injury cause mixed movement disorder . Dystonia define involuntary muscle contraction cause twist abnormal posture . While neurological underpinnings CP remain unknown , link low dopamine increase acetylcholine release recently report dystonia . Dopamine consider first line treatment child dystonia CP follow anticholiergic treatment trihexphenidyl . The recommendation dopaminergic treatment base need rule dopamine-responsive-dystonia , rare genetic disorder , single case study report improvement CP . A double blind study support refute use dopamine treatment dystonic CP never report . Working hypothesis Aims : In child CP due clear underlie pathology , dopamine treatment improve daily function . Methods : investigator perform double blind randomize control crossover study . 50 child age 4-18 year clear pathophysiological cause CP enrol . Each child receive dopamine placebo treatment 2 week 2 week washout interval . Participants randomize 2 group ; one receive placebo follow dopamine vice versa . The primary outcome measure , goal-attainment-scale , secondary outcome functional measure ( box block , 9 hole peg , pronation/ supination , finger sequence ) assess begin end treatment well parent questionnaire regard satisfaction side effect . Expected result : No functional improvement dopamine treatment compare placebo . Importance : supplying sufficient data support refute use dopamine treatment dystonic CP . Probable implication Medicine : may lead change medical treatment guideline child CP .</brief_summary>
	<brief_title>Dopamine Treatment Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>clear pathophysiological cause CP disable dystonia upper limb significant contracture psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>